Javascript must be enabled to continue!
Mechanism of Microbicidal Action of E-101 Solution, a Myeloperoxidase-Mediated Antimicrobial, and its Oxidative Products
View through CrossRef
ABSTRACTE-101 Solution is a first in class myeloperoxidase-mediated antimicrobial developed for topical application. It is composed of porcine myeloperoxidase (pMPO), glucose oxidase (GO), glucose, sodium chloride, and specific amino acids in an aqueous vehicle. Once activated, the reactive species hydrogen peroxide (H2O2), hypochlorous acid and singlet oxygen are generated. We evaluated the treatment effects of E-101 solution and its oxidative products on ultrastucture changes and microbicidal activity against methicillin-resistantStaphylococcus aureus(MRSA) andEscherichia coli. Time kill and transmission electron microscopy studies were performed using formulations with pMPO or GO omitted. The glutathione membrane protection assay was used to study the neutralization of reactive oxygen species. The potency of E-101 solution was also measured in the presence of serum and whole blood by MIC and MBC determinations. E-101 solution demonstrated rapid bactericidal activity and ultracellular changes in MRSA andE. colicells. When pMPO was omitted, high levels of H2O2generated from GO and glucose demonstrated slow microbicidal activity with minimal cellular damage. When GO was omitted from the formulation no antimicrobial activity or cellular damage was observed. Protection from exposure to E-101 solution reactive oxygen species in the glutathione protection assay was competitive and temporary. E-101 solution maintained its antimicrobial activity in the presence of inhibitory substances such as serum and whole blood. E-101 solution is a potent myeloperoxidase enzyme system with multiple oxidative mechanisms of action. Our findings suggest the primary site that E-101solution exerts microbicidal action is the cell membrane by inactivation of essential cell membrane components.
Cold Spring Harbor Laboratory
Title: Mechanism of Microbicidal Action of E-101 Solution, a Myeloperoxidase-Mediated Antimicrobial, and its Oxidative Products
Description:
ABSTRACTE-101 Solution is a first in class myeloperoxidase-mediated antimicrobial developed for topical application.
It is composed of porcine myeloperoxidase (pMPO), glucose oxidase (GO), glucose, sodium chloride, and specific amino acids in an aqueous vehicle.
Once activated, the reactive species hydrogen peroxide (H2O2), hypochlorous acid and singlet oxygen are generated.
We evaluated the treatment effects of E-101 solution and its oxidative products on ultrastucture changes and microbicidal activity against methicillin-resistantStaphylococcus aureus(MRSA) andEscherichia coli.
Time kill and transmission electron microscopy studies were performed using formulations with pMPO or GO omitted.
The glutathione membrane protection assay was used to study the neutralization of reactive oxygen species.
The potency of E-101 solution was also measured in the presence of serum and whole blood by MIC and MBC determinations.
E-101 solution demonstrated rapid bactericidal activity and ultracellular changes in MRSA andE.
colicells.
When pMPO was omitted, high levels of H2O2generated from GO and glucose demonstrated slow microbicidal activity with minimal cellular damage.
When GO was omitted from the formulation no antimicrobial activity or cellular damage was observed.
Protection from exposure to E-101 solution reactive oxygen species in the glutathione protection assay was competitive and temporary.
E-101 solution maintained its antimicrobial activity in the presence of inhibitory substances such as serum and whole blood.
E-101 solution is a potent myeloperoxidase enzyme system with multiple oxidative mechanisms of action.
Our findings suggest the primary site that E-101solution exerts microbicidal action is the cell membrane by inactivation of essential cell membrane components.
Related Results
PL‐101‐WK, a novel tryptophan‐ and lysine‐rich peptide with antimicrobial activity against Staphylococcus aureus
PL‐101‐WK, a novel tryptophan‐ and lysine‐rich peptide with antimicrobial activity against Staphylococcus aureus
AbstractDesigning short antimicrobial peptides (AMPs), which are active against drug‐resistant bacteria, is a promising way to find new therapeutic agents. In this research, a nove...
miR-101-5p contributes to preeclampsia via modulating the DUSP6- ERK1/2 axis
miR-101-5p contributes to preeclampsia via modulating the DUSP6- ERK1/2 axis
Abstract
Background
Preeclampsia (PE) is defined as new-onset hypertension with proteinuria or end-organ dysfunction after 20 weeks of gestation. Defective placentation du...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
BACKGROUND
Globally antimicrobial resistance is rising, and the Indian scenario is also similar to antimicrobial awareness. The study literature on awareness regarding antimi...
Myeloperoxidase and elastic-collagen frame in the formation of unstable atherosclerotic plaque in human
Myeloperoxidase and elastic-collagen frame in the formation of unstable atherosclerotic plaque in human
Background: Currently, there is a number of evidence indicating the possible involvement of myeloperoxidase in the pathogenesis of atherosclerosis. However, its role in the formati...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion
Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion
The reaction of myeloperoxidase compound I (MPO‐I) with chloride ion is widely assumed to produce the bacterial killing agent after phagocytosis. Two values of the rate constant fo...
Use of Biochemical Biomarkers to Evaluate the Role of Oxidative Stress in the Progression of COVID-19 Severity
Use of Biochemical Biomarkers to Evaluate the Role of Oxidative Stress in the Progression of COVID-19 Severity
AbstractThe role of oxidative stress and the use of biochemical biomarkers in the severity of COVID-19 was evaluated through a literature review (2020–2021) using scientific search...

